Breaking News
Subscribe Now 0
📈 Fed's first cut since 2020: Time to buy the dip? See Tech-focused stock picks Unlock AI Picks
Close

Moderna Inc (MRNA)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Moderna's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
71.80 +2.63    +3.80%
15:06:04 - Real-time Cboe. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 5,682,698
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 69.81 - 75.36
Moderna 71.80 +2.63 +3.80%

NASDAQ:MRNA Financials

 
A brief overview of the NASDAQ:MRNA financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Moderna Inc over time.

Moderna, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported revenue was USD 167 million compared to USD 1,862 million a year ago. Net loss was USD 1,175 million compared to net income of USD 79 million a year ago. Basic loss per share from continuing operations was USD 3.07 compared to basic earnings per share from continuing operations of USD 0.2 a year ago. Diluted loss per share from continuing operations was USD 3.07 compared to diluted earnings per share from continuing operations of USD 0.19 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

MRNA Income Statement

Gross margin TTM -62.99%
Operating margin TTM -91.78%
Net Profit margin TTM -116.18%
Return on Investment TTM -25.64%
 Total Revenue  Net Income
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Total Revenue 241 167 2811 1831
Gross Profit -1095 -992 476 -1570
Operating Income -1363 -1266 6 -2012
Net Income -1279 -1175 217 -3630

MRNA Balance Sheet

Quick Ratio MRQ 3.66
Current Ratio MRQ 4.09
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 10.84%
 Total Assets  Total Liabilities
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Total Assets 15680 16729 18426 19450
Total Liabilities 3968 3912 4572 5995
Total Equity 11712 12817 13854 13455

MRNA Cash Flow Statement

Cash Flow/Share TTM -8.46
Revenue/Share TTM 13.18
Operating Cash Flow  -53.91%
 Cash  Net Change in Cash
Period Ending: Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities -1274 -989 622 -1600
Cash From Investing Activities 1649 118 -538 789
Cash From Financing Activities 34 14 -109 -58
Net Change in Cash 409 -857 -25 -869
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

MRNA Comments

Write your thoughts about Moderna Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Matthew Morello
Matthew Morello 5 hours ago
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Goldman Sachs has it at a buy and $178 PT but Flavio Sacks has it as a sell with a $10 PT. hmmmmmmmmmm
joe napo
joe napo Sep 13, 2024 9:11AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
can you believe not too long ago people were buying this stock at $500 now same company same earnings nobody wants it for 60 stock market became a joke, this is what happens when kids and uneducated retail investors are allowed to invest
Leon Majanski
Leon Majanski Sep 12, 2024 9:59AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Moderna said initial FDA feedback did not support an accelerated approval based on data from a mid-stage study for its cancer vaccine developed along with Merck.
Flavio Man
Flavio Man Sep 12, 2024 9:34AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Where is Tim Coursel?
Flavio Man
Flavio Man Sep 06, 2024 10:44AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Back to $10. Stay short
Matthew Morello
Matthew Morello Sep 03, 2024 10:48PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Don't Mind Flav. He thinks all market participants should all think jUsT LiKe HiM.
Flavio Man
Flavio Man Sep 03, 2024 5:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
We got another herb in the forum: Tim Carousel. You’re also holding bags timothy?
Tim Coursel
Tim Coursel Sep 02, 2024 4:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hilarious when you see dudes shooting random numbers based of nothing XD XD
Matthew Morello
Matthew Morello Sep 02, 2024 4:12PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
source: trust me bro
Flavio Man
Flavio Man Aug 30, 2024 9:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
You must not listen to morello. He lost money on this stock since day 1. Moderna will be removed from the sp500 and return to its $10 level.
Matthew Morello
Matthew Morello Aug 15, 2024 1:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Flav you need to learn about RSI so you stop getting your face ripped off
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email